1. National Cancer Institute planning to switch drug development emphasis from compound to human cancer-oriented strategy. Cancer Lett. 10(41):1–2, 1984.
2. Division of Cancer Treatment Board approves new screening program, natural products concepts. Cancer Lett. 11(9):4–5, 1985.
3. Division of Cancer Treatment gets okay to proceed with human cell line drug screening. Cancer Lett. 13(25): 1–2, 1987.
4. Reviewers report progress in new drug prescreen system development. Cancer Lett. 15(48): 1–5, 1989.
5. Workshop on “Disease-oriented Antitumor Drug Discovery and Development”, NIH, Bethesda, MD, January 9-10, 1985.